These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34445175)

  • 1. Effect of L- to D-Amino Acid Substitution on Stability and Activity of Antitumor Peptide RDP215 against Human Melanoma and Glioblastoma.
    Maxian T; Gerlitz L; Riedl S; Rinner B; Zweytick D
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of two antitumor peptides with membrane lipids - Influence of phosphatidylserine and cholesterol on specificity for melanoma cells.
    Wodlej C; Riedl S; Rinner B; Leber R; Drechsler C; Voelker DR; Choi JY; Lohner K; Zweytick D
    PLoS One; 2019; 14(1):e0211187. PubMed ID: 30682171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies.
    Grissenberger S; Riedl S; Rinner B; Leber R; Zweytick D
    Biochim Biophys Acta Biomembr; 2020 Aug; 1862(8):183264. PubMed ID: 32151609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine.
    Riedl S; Rinner B; Schaider H; Lohner K; Zweytick D
    Biometals; 2014 Oct; 27(5):981-97. PubMed ID: 24838743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine.
    Riedl S; Leber R; Rinner B; Schaider H; Lohner K; Zweytick D
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):2918-31. PubMed ID: 26239537
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Riedl S; Rinner B; Schaider H; Liegl-Atzwanger B; Meditz K; Preishuber-Pflügl J; Grissenberger S; Lohner K; Zweytick D
    Oncotarget; 2017 Sep; 8(42):71817-71832. PubMed ID: 29069749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma cell surface-expressed phosphatidylserine as a therapeutic target for cationic anticancer peptide, temporin-1CEa.
    Wang C; Chen YW; Zhang L; Gong XG; Zhou Y; Shang DJ
    J Drug Target; 2016; 24(6):548-56. PubMed ID: 26596643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines.
    Kondo E; Tanaka T; Miyake T; Ichikawa T; Hirai M; Adachi M; Yoshikawa K; Ichimura K; Ohara N; Moriwaki A; Date I; Ueda R; Yoshino T
    Mol Cancer Ther; 2008 Jun; 7(6):1461-71. PubMed ID: 18566217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor activities of peptides corresponding to conserved complementary determining regions from different immunoglobulins.
    Figueiredo CR; Matsuo AL; Massaoka MH; Polonelli L; Travassos LR
    Peptides; 2014 Sep; 59():14-9. PubMed ID: 24972300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel interleukin-13 receptor alpha 2-targeted hybrid peptide for effective glioblastoma therapy.
    Kurihara R; Horibe T; Shimizu E; Torisawa A; Gaowa A; Kohno M; Kawakami K
    Chem Biol Drug Des; 2019 Jul; 94(1):1402-1413. PubMed ID: 30903640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma.
    Redko B; Tuchinsky H; Segal T; Tobi D; Luboshits G; Ashur-Fabian O; Pinhasov A; Gerlitz G; Gellerman G
    Oncotarget; 2017 Jan; 8(1):757-768. PubMed ID: 27768593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lectin-anticancer peptide fusion demonstrates a significant cancer-cell-selective cytotoxic effect and inspires the production of "clickable" anticancer peptide in Escherichia coli.
    Pasupuleti R; Riedl S; Saltor Núñez L; Karava M; Kumar V; Kourist R; Turnbull WB; Zweytick D; Wiltschi B
    Protein Sci; 2023 Dec; 32(12):e4830. PubMed ID: 37916438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells.
    Papo N; Shai Y
    Biochemistry; 2003 Aug; 42(31):9346-54. PubMed ID: 12899621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective apoptosis-inducing activity of synthetic hydrocarbon-stapled SOS1 helix with d-amino acids in H358 cancer cells expressing KRAS
    Xu LL; Li CC; An LY; Dai Z; Chen XY; You QD; Hu C; Di B
    Eur J Med Chem; 2020 Jan; 185():111844. PubMed ID: 31706640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo.
    Figueiredo CR; Matsuo AL; Azevedo RA; Massaoka MH; Girola N; Polonelli L; Travassos LR
    Sci Rep; 2015 Sep; 5():14310. PubMed ID: 26391685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and Evaluation of Gemini Surfactant-Based Lipoplexes Modified with Cell-Binding Peptide for Targeted Gene Therapy in Melanoma Model.
    Mohammed-Saeid W; Soudy R; Tikoo R; Kaur K; Verrall RE; Badea I
    J Pharm Pharm Sci; 2018; 21(1):363-375. PubMed ID: 30266136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide R18H from BRN2 Transcription Factor POU Domain Displays Antitumor Activity In Vitro and In Vivo and Induces Apoptosis in B16F10-Nex2 Cells.
    da Cunha FFM; Mugnol KCU; de Melo FM; Nascimento MVSQ; de Azevedo RA; Santos RTS; Magalhães JA; Miguel DC; Tada DB; Mortara RA; Travassos LR; Arruda DC
    Anticancer Agents Med Chem; 2019; 19(3):389-401. PubMed ID: 30417795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic Peptide ΔM4-Induced Cell Death Associated with Cytoplasmic Membrane Disruption, Mitochondrial Dysfunction and Cell Cycle Arrest in Human Melanoma Cells.
    Santa-González GA; Patiño-González E; Manrique-Moreno M
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33276536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-necrotic Activity of Cationic Mastoparan Peptides in Human Glioblastoma Multiforme Cells Via Membranolytic Action.
    da Silva AMB; Silva-Gonçalves LC; Oliveira FA; Arcisio-Miranda M
    Mol Neurobiol; 2018 Jul; 55(7):5490-5504. PubMed ID: 28965321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial Synthesis to Identify a Potent, Necrosis-Inducing Rhenium Anticancer Agent.
    Konkankit CC; Vaughn BA; MacMillan SN; Boros E; Wilson JJ
    Inorg Chem; 2019 Mar; 58(6):3895-3909. PubMed ID: 30793900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.